[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Race Oncology announces new clinical programs for AML and NSCLC, with RC220 poised to advance treatment standards. The company's latest social posts highlight these developments, generating significant engagement.
Race Oncology Limited is an Australian company focused on developing cancer treatments.
Engagements 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXXX +32%
X Months: XXXXXXX -XX%
X Year: XXXXXXX -XX%
1-Year High: XXXXX on 2025-06-27
1-Year Low: X on 2025-01-11
Engagements by network (24h): X: X
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
X Week: X -XX%
X Month: XX +89%
X Months: XXX +55%
X Year: XXXXX +187%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-01-11
Mentions by network (24h): X: X
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $rac in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: XX
X Week: X -XX%
X Month: XX +32%
X Months: XXX +305%
X Year: XXX +430%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-01-11
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$RAC - #RaceOncology - new clinical programs focused on AML and EGFR-mutated NSCLC RC220 is set to redefine o#ncology treatment standards. 🚀 #samso #samsonews #samsoinsights #coffeewithsamso #asxnews #asxcompanyresearch #independentasxcompanyresearch"
X Link @Samso_Insights 2025-12-04T23:24Z 2158 followers, XXX engagements